Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals

Author: Zhang, T.; Li, L.; Shang, Q.; Lv, C.F.; Wang, C.Y.; Su, B. Description: Type 2 diabetes mellitus (T2DM) is a major public health problem in China. Diagnostic markers are urgently needed to identify individuals at risk of developing T2DM and thus encouraging healthier life styles. Circulating miRNAs are valuable sources for non-invasive biomarkers of various diseases. The aim of this study was to examine whether reduced miR-126 expression could predict the onset of T2DM in susceptible individuals. Two groups of study subjects were involved, one group was diagnosed T2DM…

See more and a link to full text

Animal models of obesity and diabetes mellitus

Author: Kleinert, M.; Clemmensen, C.; Hofmann, S.M.; Moore, M.C.; Renner, S.; Woods, S.C.; Huypens, P.; Beckers, J.; de Angelis, M.H.; Schurmann, A.; Bakhti, M.; Klingenspor, M.; Heiman, M.; Cherrington, A.D.; Ristow, M.; Lickert, H.; Wolf, E.; Havel, P.J.; Muller, T.D.; Tschop, M.H. Description: More than one-third of the worldwide population is overweight or obese and therefore at risk of developing type 2 diabetes mellitus. In order to mitigate this pandemic, safer and more potent therapeutics are urgently required. This necessitates the continued use of animal models to discover, validate and…

See more and a link to full text

Circulating microRNAs as novel biomarkers for diabetes mellitus

Author: Guay, C.; Regazzi, R. Description: Diabetes mellitus is characterized by insulin secretion from pancreatic beta cells that is insufficient to maintain blood glucose homeostasis. Autoimmune destruction of beta cells results in type 1 diabetes mellitus, whereas conditions that reduce insulin sensitivity and negatively affect beta-cell activities result in type 2 diabetes mellitus. Without proper management, patients with diabetes mellitus develop serious complications that reduce their quality of life and life expectancy. Biomarkers for early detection of the disease and identification of individuals at risk of developing complications would greatly…

See more and a link to full text

Social support and glycemic control in adult patients with type 2 diabetes mellitus

Author: Chew, B.H.; Khoo, E.M.; Chia, Y.C. Description: INTRODUCTION: The purpose of this study is to examine the prevalence of social support and its association with glycemic control in patients with type 2 diabetes mellitus (T2D) in an urban primary care center within an academic institution. Social support is important in the management of chronic diseases. However, its association with glycemic control has been controversial. METHODS: This was part of a study examining religiosity in T2D patients. Nonsmoking patients with T2D for at least 3 years and aged 30 years…

See more and a link to full text

miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?

Author: Bhatia, P.; Raina, S.; Chugh, J.; Sharma, S. Description: Type 2 diabetes mellitus (T2DM) has reached epidemic proportions and is associated with peripheral insulin resistance. The currently used therapies aim to delay progression of T2DM. Their efficacy could drastically be improved if implemented at earlier stages. Classical diagnostic markers (blood glucose and HbA1C) are generally detected once metabolic imbalance has already set in. Therefore, development of biomarkers for early diagnosis would help identify individuals at risk for developing T2DM. Along with genetic predisposition, epigenetics also plays a major role…

See more and a link to full text

Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders

Author: Ratter-Rieck, Jacqueline M.; Roden, Michael; Herder, Christian Description: Climate change will be a major challenge for the world’s health systems in the coming decades. Elevated temperatures and increasing frequencies of heat waves, wildfires, heavy precipitation and other weather extremes can affect health in many ways, especially if chronic diseases are already present. Impaired responses to heat stress, including compromised vasodilation and sweating, diabetes-related comorbidities, insulin resistance and chronic low-grade inflammation make people with diabetes particularly vulnerable to environmental risk factors, such as extreme weather events and air pollution. Additionally,…

See more and a link to full text

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

Author: Knowler, William C.; Barrett-Connor, Elizabeth; Fowler, Sarah E.; Hamman, Richard F.; Lachin, John M.; Walker, Elizabeth A.; Nathan, David M.; Diabetes Prevention Program Research Group Description: BACKGROUND: Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors–elevated plasma glucose concentrations in the fasting state and after an oral glucose load, overweight, and a sedentary lifestyle–are potentially reversible. We hypothesized that modifying these factors with a lifestyle-intervention program or the administration of metformin would prevent or delay the development of diabetes. METHODS: We randomly…

See more and a link to full text

Dose-response issues concerning physical activity and health: an evidence-based symposium

Author: Kesaniemi, Y. K.; Danforth, E.; Jensen, M. D.; Kopelman, P. G.; Lefebvre, P.; Reeder, B. A. Description: Regular physical activity is widely accepted as a behavior to reduce all-cause mortality rates and to improve a number of health outcomes. On October 11–15, 2000, Health Canada and the United States Centers for Disease Control and Prevention sponsored a scientific symposium to determine whether there is a dose-response relationship between physical activity and several health-related outcomes and to identify areas for future research. Subject headings: Adult, Age Factors; Aged, Anxiety Disorders;…

See more and a link to full text

Chronic Consumption of Artificial Sweetener in Packets or Tablets and Type 2 Diabetes Risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study

Author: Fagherazzi, Guy; Gusto, Gaelle; Affret, Aurelie; Mancini, Francesca Romana; Dow, Courtney; Balkau, Beverley; Clavel-Chapelon, Francoise; Bonnet, Fabrice; Boutron-Ruault, Marie-Christine Description: BACKGROUND: The influence of artificial sweeteners on metabolic diseases is controversial. Artificially sweetened beverages have been associated with an increased risk of type 2 diabetes (T2D) but biases and reverse causation have been suspected to have influenced the observed association. In addition, it has been suggested that investigation into the relationship between the frequency and duration of the consumption of packet or tablet artificial sweeteners and T2D risk is…

See more and a link to full text

Lessons from the glitazones: a story of drug development

Author: Gale, E.A. Description: Troglitazone, the first in the thiazolidinedione class of oral hypoglycaemic agents, was launched in the USA in March, 1997. It reached Europe later that year, only to be withdrawn within weeks on the grounds of liver toxicity. Meanwhile it went on to generate sales of over $2 billion in the USA, and caused at least 90 cases of liver failure (70 resulting in death or transplantation) before it was withdrawn in March, 2000. Rosiglitazone and pioglitazone reached the US market in 1999 as first-line agents to…

See more and a link to full text
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.